Founded in 1929 in Barcelona, Spain, REIG JOFRE is a family-run pharmaceutical company, listed on the Spanish stock exchange's continuous market, dedicated to the research, development, manufacture and marketing of pharmaceutical products and food supplements at its four plants in Toledo (2), Barcelona (Spain) and Malmö (Sweden).
REIG JOFRE organizes its product development activities into three business divisions:
- Pharmaceutical Technologies specializing in sterile and lyophilized injectables and penicillin-derived antibiotics.
- Specialty Pharmacare specializing in dermatology and osteoarticular disorders, mainly.
- Consumer Healthcare with consumer products under the Forté Pharma brand mostly in France, Belgium, Spain and Portugal, and other OTC areas.
REIG JOFRE has more than 1,100 employees, direct sales in 8 countries (Spain, France, Portugal, Belgium, Sweden, United Kingdom, Poland, and Singapore), and 160 business partners in more than 70 countries. The company closed 2022 with turnover of €271 million.
REIG JOFRE is listed under the code BME:RJF.